Simethicone as Part of ERAS in Bariatric Surgery Patients
Madigan Army Medical Center · NCT06812832
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–89 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 4
- Target enrollment
- 260
- US sites recruiting
- 1
- Study start
- April 8, 2025
- Record last updated
- June 15, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
By conducting this study, we hope to assess if simethicone (also known as Gas Relief or GasX) has an effect on improving gas pain and bloating specifically in patients undergoing foregut procedures to include bariatric procedures (sleeve gastrectomy, Roux-en-Y gastric bypass), hiatal hernia, and gastric surgery.
The purpose of this research is to gather information on the safety and effectiveness of simethicone. Simethicone (more commonly known as Gas Relief or Gas-X) relieves pressure, bloating, and fullness commonly referred to as gas. It is FDA approved. The use of this medication in this research study is consistent with labeling indications.
Being studied: Simethicone 80 MG; Placebo
Conditions: Simethicone; Bariatric Surgery; Post-operative Pain
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Foregut procedures
Exclusion Criteria
- Non-foregut procedures
- Allergy to simethicone
- Pregnancy or breastfeeding
- Minors under 18 years of age
Recruiting US locations
Madigan Army Medical Center
Tacoma, WA 98431
Site contact: Christopher Porta, MD · 253-968-3105 · christopher.r.porta.civ@health.mil
Study contacts (from the official record)
- Brooklyn Williams, DO · (253) 968-3105 · brooklyn.c.williams3.mil@health.mil
- Christopher Porta, MD · (253) 968-3105 · christopher.r.porta.civ@health.mil
Similar studies in Washington
All pain studies in Washington →- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Bellevue, WA + 57 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Eli Lilly and Company
- Location
- Kirkland, WA + 37 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Eli Lilly and Company
- Location
- Bellevue, WA + 34 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain
Eli Lilly and Company
- Location
- Bellevue, WA + 31 other US sites
- Eligibility basics
- Ages 18+